Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

Tomorrow's cardio blockbusters: Inside 'the next big leap' in controlling cholesterol, March 31, 2014 | By Damian Garde in Fierce Biotech

Excerpts:
"A new era for cardiology---Whether PCSK9 drugs can live up to their billing likely won't be decided for at least three years, but their short-term promise heralds the grand entry of biologics into the cardiology world, Libby said. As anyone inundated with TV ads for Enbrel and Humira can attest, TNF-blocking biotech drugs have revolutionized rheumatology, according to Libby, and the same thing has taken place in cancer. But for cardiology, an area long focused on small-molecule therapies with varying rates of success, drugs like evolocumab, alirocumab and bococizumab signal a new way forward.

Article at:
http://www.fiercebiotech.com/story/tomorrows-cardio-blockbusters-inside-next-big-leap-controlling-cholesterol/2014-03-31#ixzz31hyggeRA